LifeMD面临集体诉讼诉讼 指控虚假陈述和股价暴跌。 LifeMD faces class action lawsuits over alleged false statements and a plummeting stock price.

由于2025年第二季度财务业绩令人失望,股价大幅下跌,LifeMD, Inc. (LFMD) 面临多起证券集体诉讼. LifeMD, Inc. (LFMD) faces multiple securities class action lawsuits following disappointing Q2 2025 financial results and a significant drop in stock price. 指控包括虚假陈述、缺乏关键信息披露以及业务业绩夸大。 Allegations include false statements, lack of crucial information disclosure, and inflated business performance. 各律师事务所正在调查此事,并鼓励受影响的投资者为其损失寻求潜在的索赔。 Various law firms are investigating the matter and encourage affected investors to seek potential claims for their losses.